Author | Lightnews

CardioVascMMM @cardiovascmmm.bsky.social · Jun 6

Well is that the terrorisms trump was talking about before

CardioVascMMM @cardiovascmmm.bsky.social · May 18

Danke an die neue #bundesregierung für das Ende der Freizügigkeit in Europa … 45 min an der #Grenze von den Niederlanden zurück nach Deutschland….. #DankeMerz

CardioVascMMM @cardiovascmmm.bsky.social · May 14

But PAD outcomes are missing in all 4 trials that would be great additional information….

CardioVascMMM @cardiovascmmm.bsky.social · May 12

Common femoral artery dissection. Perfussed true and false lumen. #vascular #vascularsky #sonography #echosky #sonographysky #cardiosky

2

CardioVascMMM @cardiovascmmm.bsky.social · May 12

I am always wondering why pad events are not included in the outcomes….

1

Reposted by CardioVascMMM

Michael Olesen @molesen.bsky.social · May 10

About a 25% reduction of risk of cardiovascular events from the shingles vaccine, yet this administration is clearly taking an antivax stance. Impeach these fools.

academic.oup.com/eurheartj/ad...

Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study

AbstractBackground and Aims. Despite the potential association between herpes zoster infection and cardiovascular events, limited studies have investigated

academic.oup.com

13 25

CardioVascMMM @cardiovascmmm.bsky.social · May 9

Little run. #run #workout #rundayisfunday #gutenberghalbmarathon #mainz

3

CardioVascMMM @cardiovascmmm.bsky.social · Apr 27

Sunday is runday! ❤️ #workout #longrun #cologne

1

CardioVascMMM @cardiovascmmm.bsky.social · Apr 26

Hat sich meines Wissens nach auch noch nie eine aufgestellt, woher soll sie dann kommen? Ist also nen Quatsch Post der ihnen Glaubwürdigkeit nimmt, auch wenn die weibliche Representation in Führungspositionen ein unendlich wichtiges Thema ist.

CardioVascMMM @cardiovascmmm.bsky.social · Apr 26

Great talk from Dr. Macherey-Mayer on AI usage for ECG based occlusive MI detection #cardiosky #DGK #jahrestagung

1 1

CardioVascMMM @cardiovascmmm.bsky.social · Apr 21

We need to take care of our air to prevent disease!!! Treatments are improving, but we have also to forecome their need! #medicine #prevention

CardioVascMMM @cardiovascmmm.bsky.social · Apr 5

Be aware that an increased lp(a) is 6x times !!! More dangerous than LDL. #cardiosky #cardiology #lipids

2 2

CardioVascMMM @cardiovascmmm.bsky.social · Apr 5

Great Meeting at the ESVM Congress! It was a blast. #vascular #medicine #vascularmedicine #bergamo

2

CardioVascMMM @cardiovascmmm.bsky.social · Apr 1

Well, so true. But both randomized trials trials are focused on shock patients and have a neutral outcome. We all know that observational data is delicate due to serveral biases. Look at our Cardiac arrest study. academic.oup.com/eurheartj/ar...

Coronary angiography after cardiac arrest without ST-elevation myocardial infarction: a network meta-analysis

AbstractAims. This network meta-analysis aimed to assess the effect of early coronary angiography (CAG) compared with selective CAG (late and no CAG) for p

academic.oup.com

1

Reposted by CardioVascMMM

Kardioklick @kardioklick.bsky.social · Mar 31

Seems like Sotatercept is the wonder drug that it promised to be! #cardiosky

NEJM.org @nejm.org · Mar 31

ZENITH trial: Among adults with pulmonary arterial hypertension at high risk for death, sotatercept reduced the risk of a composite of death from any cause, lung transplantation, or pulmonary arterial hypertension. nej.md/4iYkLbj

#ACC25 @accintouch.bsky.social

A graph of the probability of freedom from a first event of death from any cause, lung transplantation, or hospitalization lasting at least 24 hours for worsening pulmonary arterial hypertension.

3 6

CardioVascMMM @cardiovascmmm.bsky.social · Mar 31

After the shock trial this one is also negative. Why should we consider using the iabp?

1

Reposted by CardioVascMMM

Erin Michos, MD @erinmichos.bsky.social · Mar 29

Exciting! #STRIDE trial just presented at #ACC25 @accintouch.bsky.social . #Semaglutide improved mean walking distance, symptoms, major limb events & quality of life in patients with #T2D & #PAD. We have a new drug now to help PAD patients! #CardioSky

1 10 15

CardioVascMMM @cardiovascmmm.bsky.social · Mar 30

Thats what we founf in our meta-analysis as well. But apixaban had less bleeding events and was as effective.
For sure lower quality data. link.springer.com/article/10.1...

Oral anticoagulation in patients with left ventricular thrombus: a systematic review and network meta-analysis with reconstructed time-to-event data - Clinical Research in Cardiology

Background Left ventricular thrombus (LVT) is associated with high rates of systemic embolism. Vitamin K antagonists (VKAs) are the only approved treatment for LVT. Although evidence suggests direct o...

link.springer.com

CardioVascMMM @cardiovascmmm.bsky.social · Mar 30

Interesting! Did you change any habits after you read the results of this study?

2

CardioVascMMM @cardiovascmmm.bsky.social · Mar 30

What can we take away from it for our daily practice?

CardioVascMMM @cardiovascmmm.bsky.social · Mar 29

What do you think is the reason for the missing money in the NHS? Where is the money going? Or are the people not willing to pay for healthcare?

CardioVascMMM @cardiovascmmm.bsky.social · Mar 29

Great. We need a study comaparing finerenone to spironolacton

CardioVascMMM @cardiovascmmm.bsky.social · Mar 29

That’s huge! A reduction in MALE is exactly what we need for these patients, given their significant disease burden.

1

CardioVascMMM @cardiovascmmm.bsky.social · Mar 29

Super interesting and highly relevant! I’m particularly curious about the subgroups—are there differences in the risk of recurrent events depending on the type of cancer?

1

CardioVascMMM @cardiovascmmm.bsky.social · Mar 29

Super interesting and highly relevant! I’m particularly curious about the subgroups—are there differences in the risk of recurrent dvt events depending on the type of cancer?